Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2021

Dec 8, 2021

29841_dirs_2021-12-07_07135d7f-86bf-4356-9d89-6145de2f16fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-12-06

Reporting Person: PARKHILL KAREN L (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-06 Ordinary Shares G 49859 Disposed 0 Indirect
2021-12-06 Ordinary Shares G 49859 Acquired 49859 Indirect
2021-12-06 Ordinary Shares S 682 $110.00 Disposed 35446 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 843 Indirect
Ordinary Shares 843 Indirect
Ordinary Shares 843 Indirect

Footnotes

F1: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.

F2: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3: This balance increased by 154 shares due to exempt transactions such as dividend reinvestment.